DJIA 15,660.18 -254.56 -1.60%
NASDAQ 4,266.84 -16.76 -0.39%
S&P 500 1,829.08 -22.78 -1.23%
market minute promo

Eli Lilly & Co. (NYSE: LLY)

71.42 -1.65 (-2.26%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

LLY $71.42 -2.26%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $72.20
Previous Close $73.07
Daily Range $70.83 - $72.63
52-Week Range $68.31 - $92.85
Market Cap $79.1B
P/E Ratio 21.30
Dividend (Yield) $2.04 (2.8%)
Ex-Dividend Date
Dividend Pay Date
Volume 5,382,678
Average Daily Volume 5,537,164
Current FY EPS $3.42




Drug Makers

Eli Lilly & Co. (LLY) Description

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases. Website:

News & Commentary

2 Numbers in Merck's 4th-Quarter Report That Have Investors Worried

Merck may have surpassed Wall Street's profit forecast, but these two numbers suggest that growth may be challenged in 2016.

Alkermes' ALKS 3831 in 2nd Phase III Study for Schizophrenia

MTUM, HD, LLY, TWC: ETF Inflow Alert

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

Novo Nordisk: Don't Get Scared By Foolish Investor Sentiment

Novo Nordisk A/S Taps the Growth Brakes

The diabetes specialist expects to see slowing operating growth, but it has a good reason.

ImmunoGen, Inc.'s Earnings Play the Amortization Blues

Keep focused on the pipeline because revenue and earnings are going to be bumpy for some time.

See Which Of The Latest 13F Filers Holds Eli Lilly

Wall Street Is as Bearish as 2009: 4 Top Dividend Stocks to Buy Right Now

3 Numbers That Matter When Merck Reports Its Fourth-Quarter Results

These three figures may prove far more important than Merck's fourth-quarter and full-year headline results.

See More LLY News...

LLY's Top Competitors

LLY $71.42 (-2.26%)
Current stock: LLY
JNJ $101.70 (-0.03%)
Current stock: JNJ
NVS $72.20 (-1.08%)
Current stock: NVS
RHHBY $31.14 (-0.75%)
Current stock: RHHBY